Sagility B.V., the promoter of Sagility India Ltd, has announced its intention to sell up to a 15.02% stake in Sagility India through a secondary market transaction, setting the floor price at ₹38 per share, according to a recent regulatory filing.
Key Highlights:
-
Sagility B.V. is proposing to divest up to 15.02% of its holding in Sagility India, a leading technology-enabled healthcare services provider.
-
The floor price for the stake sale has been fixed at ₹38 per share, which is notably below the current market price of around ₹42.65 per share as of May 26, 2025.
-
The proposed sale is structured as an Offer for Sale (OFS), meaning the entire proceeds will accrue to the selling promoter and not the company itself.
-
Sagility India’s recent financials show robust growth, with consolidated net sales for March 2025 at ₹1,568.48 crore, marking a 22.23% year-on-year increase.
-
The company’s market capitalization stands at approximately ₹20,045 crore, with a 52-week price range between ₹27.02 and ₹56.40.
-
The OFS is expected to enhance liquidity for existing shareholders and increase the company’s public float, aligning with objectives previously outlined during its IPO process.
-
Employee reservation and institutional investor participation are likely, consistent with Sagility India’s prior public offerings.
Sagility India, headquartered in Bengaluru, specializes in serving U.S. healthcare payers and providers, with a workforce exceeding 35,000 employees and a strong track record of operational and profit growth.
This development is poised to attract significant attention from institutional and retail investors, given the company’s sectoral leadership and recent financial outperformance.
Source: Moneycontrol, BizzBuzz, Global Prime News